Rita M. O'Connor
2018
In 2018, Rita M. O'Connor earned a total compensation of $462.5K as Chief Financial Officer at Dipexium Pharmaceuticals, a 2% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $150,000 |
|---|---|
| Salary | $300,000 |
| Other | $12,500 |
| Total | $462,500 |
O'Connor received $300K in salary, accounting for 65% of the total pay in 2018.
O'Connor also received $150K in non-equity incentive plan and $12.5K in other compensation.
Rankings
In 2018, Rita M. O'Connor's compensation ranked 12,130th out of 14,244 executives tracked by ExecPay. In other words, O'Connor earned more than 14.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 12,130 out of 14,244 | 15th |
Division Manufacturing | 4,907 out of 5,758 | 15th |
Major group Chemicals And Allied Products | 1,852 out of 2,119 | 13th |
Industry group Drugs | 1,581 out of 1,808 | 13th |
Industry Pharmaceutical Preparations | 1,211 out of 1,382 | 12th |
Source: SEC filing on September 25, 2020.
O'Connor's colleagues
We found three more compensation records of executives who worked with Rita M. O'Connor at Dipexium Pharmaceuticals in 2018.